A Pilot Retrospective Study Validating Noncommunicable Disease Risk Assessment Score (AMNRAS)

Arti Gupta, Sathiyanarayanan S, Rajeev Aravindakshan, Rakesh Kakkar


Background: Globally Noncommunicable Diseases is lead causes of mortality. This calls for the need of sensitive and cost appropriate screening tools to identify asymptomatic healthy individuals with higher risk and/or subclinical NCD in the community. The study aims to generate pilot evidence based, validated, good quality, cost appropriate, and sustainable risk assessment score for NCD for developing countries like India. Methods: This descriptive retrospective study of diabetic camp data of 84 patients was conducted. A risk score having 10 questions and three measurements for NCDs appropriate for Indian communities was generated. It was compared to IDRS, FINDRISC, FRS, CBAC, and WHO/ISH prediction charts. Results: The study finally included 36 patients with NCD as case and 44 subjects without NCD as control. The means of weight, waist circumference, blood pressure, and blood sugar were significantly different among the two groups. AMNRAS of more than 14 was highly predictive for an individual to be at risk of NCD or sub clinical case of NCD requiring evaluation. The proposed cut‑off of 8 for AMNRAS, the sensitivity and NPV was highest compared to other score, 88.9% and 84.6%, respectively. Score for the Area under curve was significantly higher for AMNRAS [0.83 (0.74 to 0.92)] compared to other scores. Conclusions: AMNRAS has higher performance parameters than the other five tested in the present study. Other scoring system performs only modestly in discrimination of NCD cases. The accuracy of AMNRAS for NCD risk will have to be determined in large size cohorts


Cardiovascular diseases; checklist; diabetes mellitus; dietary; noncommunicable disease; obesity; risk factors; tobacco; waist circumference

Full Text:



NCD mortality and morbidity, Global Health Observatory (GHO)

data. Available from: https://www.who.int/gho/ncd/mortality_

morbidity/en/. [Last accessed on 2019 Apr 10].

Burden of NCDs and their risk factors in India. Available

from: http://www.searo.who.int/india/topics/noncommunicable_


[Lastaccessed on 2019 Apr 08].

Global action plan For the prevention and control of

Noncommunicable Diseases. World Health Organization.

Available from: https://apps.who.int/iris/bitstream/


A123E519DA6847DB8020D?sequence=1. [Last accessed on 2019 Apr 15].

NCDs, poverty and development. WHO Global Coordination

Mechanism on the Prevention and Control of NCDs. Available fro

m: https://www.who.int/global‑coordination‑mechanism/povertyand‑development/en/. [Last accessed on 2019 Apr 10].

Module for Multi‑Purpose Workers (MPW)‑Female/

Male on Prevention, Screening and Control of Common

Non‑Communicable Diseases. Available from: http://



%26%20Control%20of%20NCDs‑English.pdf. [Last accessed on

Jan 10].

Selvarajah S, Kaur G, Haniff J, Cheong KC, Hiong TG, van

der Graaf Y, et al. Comparison of the Framingham Risk Score,

SCORE and WHO/ISH cardiovascular risk prediction models in

an Asian population. Int J Cardiol 2014;176:211‑8.

FINDRISC (Finnish Diabetes Risk Score). Available from: https://

www.mdcalc.com/findrisc‑finnish‑diabetes‑risk‑score. [Last

accessed on 2019 Jan 02].

WHO/ISH cardiovascular risk prediction charts. Available

from: https://www.who.int/cardiovascular_diseases/guidelines/


file%2012.9.2007.pdf?ua=1. [Last accessed on 2019 Jan 20].

Kanjilal S, Rao VS, Mukherjee M. Application of cardiovascular

disease risk prediction models and the relevance of novel

biomarkers to risk stratification in Asian Indians. Vasc Health

Risk Manag 2008;4:199–211.

Mohan V, Deepa R, Deepa M, Somannavar S,

Datta M. A simplified Indian Diabetes risk score

for screening for undiagnosed diabetic subjects.

J Assoc Physicians India 2005;53:759‑63.

General CVD Risk Prediction Using BMI. Available from:




ovasculardisease%2Fheartage.html. [Last accessed on 2019 Jan


Dudeja P, Singh G, Gadekar T, Mukherji S. Performance of

Indian Diabetes Risk Score (IDRS) as screening tool for diabetes

in an urban slum. Med J Armed Forces India 2016;73:123–8.

Gomez‑Arbelaez D, Alvarado‑Jurado L, Ayala‑Castillo M,

Forero‑Naranjo L, Camacho PA, Lopez‑Jaramillo P. Evaluation

of the Finnish Diabetes Risk Score to predict type 2 diabetes

mellitus in a Colombian population: A longitudinal observational

study. World J Diabetes 2015;6:1337–44.

Ghorpade AG, Shrivastava SR, Kar SS, Sarkar S, Majgi SM,

Roy G. Estimation of the cardiovascular risk using World Health

Organization/International Society of Hypertension (WHO/ISH)

risk prediction charts in a rural population of South India. Int J

Health Policy Manag 2015;4:531–6.

Evaluation of diagnostic and screening tests: Validity and reliability.

The Johns Hopkins University and Sukon Kanchanaraksa.

Available from: http://ocw.jhsph.edu/courses/FundEpi/PDFs

/Lecture11.pdf. [Last accessed on 2019 Jan


Pawar SD, Naik JD, Prabhu P, Jatti GM, Jadhav SB, Radhe BK.

Comparative evaluation of Indian Diabetes Risk Score and

Finnish Diabetes Risk Score for predicting risk of diabetes

mellitus type II: A teaching hospital‑based survey in Maharashtra.

J Family Med Prim Care 2017;6:120–5.

Zhang L, Zhang Z, Zhang Y, Hu G, Chen L. Evaluation of

Finnish Diabetes Risk Score in screening undiagnosed diabetes

and prediabetes among U.S. adults by gender and race: NHANES

‑2010. PLoS One 2014;9:e97865.